Operating CF
$7.61B
Capex
−$1.16B
Free Cash Flow
$6.45B
FCF Margin
+84.8%
Cash flow waterfall for Elevance Health (ELV) — TTM through Q1 2026
Free cash flow: $6.45B
Cash flow breakdown for Elevance Health (ELV) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $7.61B | $7.61B |
| Capital Expenditure | −$1.16B | $6.45B |
| Free Cash Flow | $6.45B | $6.45B |
| Other Investing | −$1.93B | $4.52B |
| Share Buybacks | −$2.85B | $1.67B |
| Dividends Paid | −$1.52B | $148.00M |
| Net Debt Change | $2.38B | $2.53B |
| Other Financing & FX | −$376.00M | $2.16B |
| Net Cash Increase | $2.16B | $2.16B |
- Operating Cash Flow$7.61B
- Capital Expenditure−$1.16B
- Free Cash Flow$6.45B
- Other Investing−$1.93B
- Share Buybacks−$2.85B
- Dividends Paid−$1.52B
- Net Debt Change$2.38B
- Other Financing & FX−$376.00M
- Net Cash Increase$2.16B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement